Prior to immunohistochemical study, the CXCR4 antibody was used in Western blotting where CXCR4 protein levels were decreased and increased by NRN1 silencing and overexpression in RCC-PDC1 cells, respectively (Supplementary Figures 5A, B). This evidence concerns the gene CXCR4 and renal cell carcinoma.